Liposome longevity and stability in circulation: Effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines

Journal of Drug Targeting

Volumn 3, Issue 5, 1996, Pages 391-398

  Gabizon, A ^a   Chemla, M ^a   Tzemach, D ^a   Horowitz, A T ^a   Goren, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Animal tumors; Anthracyclines; Chemotherapy; Liposomes; Pharmacokinetics

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; LIPOSOME; MACROGOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; DRUG TUMOR LEVEL; ENCAPSULATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0030042023     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869608996830     Document Type: Article

References (26)

1. Cowens J.W., Creaven P.J., Greco W.R., Brenner D.E., Yung T., Ostro M., Pilkiewicz F., Ginsberg R., and Petrelli N. (1993) Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res. 53:2796-2802.
2. Forssen E.A., Coulter D.M., and Proffitt R.T. (1992) Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res. 52:3255.
3. Gabizon A., and Trainin N. (1980) Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br. J. Cancer 42:551-558.
4. Gabizon A., Dagan A., Goren D., Barenholz Y., and Fuks Z. (1982) Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 42:4734-4739.
5. Gabizon A., and Papahadjopoulos D. (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 55:6949-6953.
6. Gabizon A., Price D.C., Huberty J., Bresalier R.S., and Papahadjopoulos D. (1990) Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res. 50:6371-6378.
7. Gabizon A. (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52:891-896.
8. Gabizon A., Barenholz Y., and Bialer M. (1993) Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethyleneglycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharm. Res. 10:703-708.
9. Gabizon A. (1994) Liposomal anthracyclines. Hematol. Oncol. Clin North Am. 8:431-450.
10. Gill P.S., Espina B.M., Muggia F., Cabriales S., Tulpule A., Esplin J.A., Liebman H.A., Forssen E., Ross M.E., and Levine A.M. (1995) Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J. Clin. Oncol. 13:996-1003.
11. Haran G., Cohen R., Bar L.K., and Barenholz Y. (1993) Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 2152:201-215.
12. Harrison M, Tomlinson D., and Stewart S. (1995) Liposomal-entrapped doxorubicin: An active agent in AIDS-related Kaposi's sarcoma. J. Clin. Oncol. 13:914-920.
13. Huang S.K., Lee K.D., Hong K., Friend D.S., and Papahadjopoulos D. (1992a) Microscopic localization of sterically-stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52:5135-5143.
14. Huang S.K., Mayhew E., Gilani S., Lasic D.D., Martin F.J., and Papahadjopoulos D. (1992b) Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52:6774-6781.
15. Lasic D.D., Martin F.J., Gabizon A., Huang S.K., and Papahdjopoulos D. (1991) Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 2070:187-192.
16. Lichtenberg D., and Barenholz Y. (1988) Liposomes: Preparation, characterization and preservation. In, Methods of Biochemical Analysis (Ed. D. Glick), Wiley, New York, 33:337-463.
17. Marks T.A., Woodman R.J., Geran R.J., Billups L.H., and Madison R.M. (1977) Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Cancer Treat. Rep. 61:1459-1470.
18. Mayer L.D., Bally M.B., Hope M.J , and Cullis P.R. (1985) Uptake of antineoplastic agents into large unilamellar vesicles in response to membrane potential. Biochim. Biophys. Acta 816:294-302.
19. Mayer L.D., Tai L.C., Ko D.S., Masin D., Ginsberg R.S., Cullis P.R., and Bally M.B. (1989) Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49:5922-5930.
20. Mayhew E.G., Lasic D.D., Babbar S., and Martin F.J. (1992) Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes. Int. J. Cancer 51:302-309.
21. Papahadjopoulos D., Allen T, Gabizon A., Mayhew E., Matthay K., Huang S.K , Lee K.D., Woodle M.C, Lasic D.D., Redemann C., and Martin F.J. (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and anti-tumor therapeutic efficacy. Proc. Natl. Acad. Sci U.S.A. 53:11460-11464.
22. Storm G., Van Bloois L., Brouwer M., and Crommelin D.J. (1985) The interaction of cytostatic drugs with adsorbents in aqueous media-The potential implications for liposome preparation. Biochim. Biophys. Acta 815:343-351.
23. Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Tsao D., Yehoshua Z., Muggia F.M., and Gabizon A. (1995) Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol. 13:1777-1785.
24. Vaage J., Mayhew E., Lasic D., and Martin F.J. (1992) Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes. Int. J. Cancer 51:942-948.
25. Williams S.S., Alosco T.R., Mayhew E., Lasic D.D., Martin F.J., and Bankert R.B. (1993) Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res. 53:3964-3967.
26. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., and Jain R.K. (1994) Microvascular and interstitial penetration of Sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 54:3352-3356.